Financial Performance - Adjusted operating income, excluding notable items, was $6371 per diluted share[15] - Trailing twelve month adjusted operating ROE, excluding notable items, was 142%[15] - The company deployed approximately $17 billion of capital during the quarter into in-force block transactions, including $15 billion into the EQH transaction[15] Business Growth and Momentum - Traditional premium growth was 85% year-to-date on a constant currency basis[15] - Value of In-force Business Margins increased by $61 billion, or 162%, to $437 billion in the first nine months of the year[15] Capital Management - Estimated deployable capital is $34 billion[15] - Estimated excess capital totaled $23 billion[15] - The company repurchased $75 million of common shares[15] Investment Portfolio - Assets under management are approximately $132 billion[31] - Over 94% of fixed maturity securities are rated investment-grade[31] - The company experienced Q3 impairments and change in allowances of $35 million[35]
RGA(RGA) - 2025 Q3 - Earnings Call Presentation
